Details of Disease

General Information of Disease (ID: DISMT6UV)

Disease Name	Urinary tract infection
Synonyms	urinary tract infection (disease)
Disease Class	GC08: Urinary tract infection
Disease Hierarchy	DIS0HU8N: Urinary tract disease DISEM33Q: Infectious disease DISMT6UV: Urinary tract infection
ICD Code	ICD-11 ICD-11: GC08 ICD-10 ICD-10: N39, N39.0
Disease Identifiers	MONDO ID MONDO_0100338 UMLS CUI C0042029 MedGen ID 52943 SNOMED CT ID 68566005

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)

This Disease is Treated as An Indication in 57 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Acetohydroxamic	DM16GO3	Approved	NA	[1]
Acetohydroxamic Acid	DMYX7NI	Approved	Small molecular drug	[2]
Ammonium chloride	DMPJCXG	Approved	Small molecular drug	[3]
Amoxicillin	DMUYNEI	Approved	Small molecular drug	[4]
Amphotericin B	DMTAJQE	Approved	Small molecular drug	[5]
Ampicillin	DMHWE7P	Approved	Small molecular drug	[6]
Azlocillin	DMIR5QP	Approved	Small molecular drug	[7]
Aztreonam	DMDNJHG	Approved	Small molecular drug	[8]
Bacampicillin	DMP54C7	Approved	Small molecular drug	[9]
Carbenicillin	DMLEDNK	Approved	Small molecular drug	[10]
Cefaclor	DMJXDGC	Approved	Small molecular drug	[11]
Cefadroxil	DMMC345	Approved	Small molecular drug	[12]
Cefalotin	DMVYSLE	Approved	Small molecular drug	[13]
Cefamandole	DMNEXZF	Approved	Small molecular drug	[14]
Cefiderocol	DMJSMDL	Approved	Small molecular drug	[15]
Cefixime	DMY60I8	Approved	Small molecular drug	[16]
Cefmetazole	DM42W1B	Approved	Small molecular drug	[17]
Cefonicid	DMTX2BH	Approved	Small molecular drug	[18]
Cefradine	DMUNSWV	Approved	Small molecular drug	[19]
Ceftezole	DMX47U6	Approved	Small molecular drug	[20]
Ceftizoxime	DM3VOGS	Approved	Small molecular drug	[21]
Cephapirin	DMV2JNY	Approved	Small molecular drug	[22]
Cinoxacin	DM4EWNS	Approved	Small molecular drug	[20]
Clavulanate	DM2FGRT	Approved	Small molecular drug	[23]
Cotrimazine	DMPEFHD	Approved	NA	[20]
Cyclacillin	DMHSJB4	Approved	Small molecular drug	[24]
Demeclocycline	DMZEPFJ	Approved	Small molecular drug	[25]
Doripenem	DM9UCJK	Approved	Small molecular drug	[26]
Enoxacin	DMYTE6L	Approved	Small molecular drug	[27]
Erythromycin	DM4K7GQ	Approved	Small molecular drug	[28]
Finafloxacin	DMZEONG	Approved	Small molecular drug	[29]
Fosfomycin	DMVGPMX	Approved	Small molecular drug	[30]
Framycetin	DMF8DNE	Approved	Small molecular drug	[31]
Fusidic Acid	DMWVCF3	Approved	Small molecular drug	[32]
Kanamycin	DM2DMPO	Approved	Small molecular drug	[33]
Lomefloxacin	DMVRH9C	Approved	Small molecular drug	[34]
Methenamine	DMO794W	Approved	Small molecular drug	[20]
Mezlocillin	DMY5JEP	Approved	Small molecular drug	[35]
Minocycline	DMVN5OH	Approved	Small molecular drug	[36]
Nalidixic Acid	DMRM0JV	Approved	Small molecular drug	[37]
Nitrofurantoin	DM7PQIK	Approved	Small molecular drug	[38]
Norfloxacin	DMIZ6W2	Approved	Small molecular drug	[39]
Ofloxacin	DM0VQN3	Approved	Small molecular drug	[40]
Oxytetracycline	DMOVH1M	Approved	Small molecular drug	[41]
Piperacillin	DMTBKF3	Approved	Small molecular drug	[42]
Pivmecillinam	DMDU0BV	Approved	Small molecular drug	[43]
Plazomicin	DMKMBES	Approved	Small molecular drug	[44]
Polymyxin B Sulfate	DMN0LP8	Approved	Small molecular drug	[45]
Prulifloxacin	DMOK965	Approved	Small molecular drug	[46]
Sulfacytine	DMKI2XC	Approved	Small molecular drug	[47]
Sulfamethizole	DMGCHDS	Approved	Small molecular drug	[48]
Sulfisoxazole	DMXLT8C	Approved	Small molecular drug	[20]
Tetracycline	DMZA017	Approved	Small molecular drug	[49]
Ticarcillin	DM4ME02	Approved	Small molecular drug	[50]
Trimethoprim	DMM7CHK	Approved	Small molecular drug	[51]
Trovafloxacin	DM6AN32	Approved	Small molecular drug	[52]
Vitamin C	DMXJ7O8	Approved	Small molecular drug	[53]
------------------------------------------------------------------------------------


⏷ Show the Full List of 57 Drug(s)

This Disease is Treated as An Indication in 15 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Enmetazobactam	DMZKTYJ	Phase 3	Small molecular drug	[54]
GSK2140944	DMSMFN2	Phase 3	NA	[55]
Sulopenem	DMMD856	Phase 3	Small molecular drug	[56]
Tebipenem	DMVSX6O	Phase 3	Small molecular drug	[57]
Vaborbactam	DMDCFXJ	Phase 3	Small molecular drug	[58]
Benapenem	DMUBTMF	Phase 2/3	Small molecular drug	[59]
LACTIN-V	DMOAPGT	Phase 2/3	NA	[60]
GSK-2251052	DMLFI7Q	Phase 2	Small molecular drug	[61]
LYS228	DM23Y6K	Phase 2	Small molecular drug	[62]
C-1205	DML5P59	Phase 1	Small molecular drug	[63]
ETX0282	DMUBD0I	Phase 1	Small molecule	[64]
GSK3882347	DM1DU20	Phase 1	Small molecule	[65]
LBP-EC01	DMKRGIZ	Phase 1	NA	[66]
RG6319	DMUM6MK	Phase 1	NA	[67]
UTI vaccine	DM0X1SV	Phase 1	NA	[68]
------------------------------------------------------------------------------------


⏷ Show the Full List of 15 Drug(s)

This Disease is Treated as An Indication in 188 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Alkyl mannoside derivative 1	DMW57UB	Patented	Small molecular drug	[69]
Alkyl mannoside derivative 10	DMHD51F	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 11	DMMNZ2U	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 12	DMX1OZF	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 2	DMNQUKP	Patented	Small molecular drug	[69]
Alkyl mannoside derivative 3	DML2B58	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 4	DMZR71O	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 5	DM04ZJ2	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 6	DMCIV32	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 7	DMBLSH1	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 8	DMZP1JT	Patented	Carbohydrates	[69]
Alkyl mannoside derivative 9	DMV1QUX	Patented	Carbohydrates	[69]
Aryl mannoside derivative 1	DM1TV6F	Patented	Carbohydrates	[69]
Aryl mannoside derivative 10	DM251GL	Patented	Carbohydrates	[69]
Aryl mannoside derivative 11	DMRVIPL	Patented	Carbohydrates	[69]
Aryl mannoside derivative 12	DMOG8XT	Patented	Carbohydrates	[69]
Aryl mannoside derivative 13	DM2W7JE	Patented	Carbohydrates	[69]
Aryl mannoside derivative 14	DMR648Z	Patented	Carbohydrates	[69]
Aryl mannoside derivative 15	DMQS8CF	Patented	Carbohydrates	[69]
Aryl mannoside derivative 16	DMP6QEC	Patented	Carbohydrates	[69]
Aryl mannoside derivative 17	DM0FSPQ	Patented	Carbohydrates	[69]
Aryl mannoside derivative 18	DM0YUBR	Patented	Carbohydrates	[69]
Aryl mannoside derivative 19	DM6K29H	Patented	Carbohydrates	[69]
Aryl mannoside derivative 2	DM4S2U5	Patented	Carbohydrates	[69]
Aryl mannoside derivative 20	DMZ2RV3	Patented	Carbohydrates	[69]
Aryl mannoside derivative 21	DMJBY68	Patented	Carbohydrates	[69]
Aryl mannoside derivative 22	DMJFDNB	Patented	Carbohydrates	[69]
Aryl mannoside derivative 23	DMWUNRV	Patented	Carbohydrates	[69]
Aryl mannoside derivative 3	DMF5XU8	Patented	Carbohydrates	[69]
Aryl mannoside derivative 4	DMO19Y6	Patented	Carbohydrates	[69]
Aryl mannoside derivative 5	DMMC31R	Patented	Carbohydrates	[69]
Aryl mannoside derivative 6	DM5MIEC	Patented	Carbohydrates	[69]
Aryl mannoside derivative 7	DM9YS40	Patented	Carbohydrates	[69]
Aryl mannoside derivative 8	DMK6PFQ	Patented	Carbohydrates	[69]
Aryl mannoside derivative 9	DMNSK7U	Patented	Carbohydrates	[69]
Beta-cyclodextrin conjugate derivative 1	DMZKTHL	Patented	Carbohydrates	[69]
Beta-cyclodextrin conjugate derivative 2	DM9W1FO	Patented	Carbohydrates	[69]
Beta-cyclodextrin conjugate derivative 3	DMQJF4P	Patented	Carbohydrates	[69]
Beta-cyclodextrin conjugate derivative 4	DMO9RE8	Patented	Carbohydrates	[69]
Beta-cyclodextrin conjugate derivative 5	DML2B7G	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 1	DMX6YGS	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 10	DMPF37N	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 11	DMKES0G	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 12	DM5T29W	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 13	DM1Y8OM	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 14	DM4C5QY	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 15	DMKXT7H	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 16	DMP9742	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 17	DMIXV6G	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 18	DMHOPE0	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 19	DME8DQ0	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 2	DMMB60X	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 20	DMNC5S0	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 21	DMGSLHN	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 22	DMYLVB3	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 23	DM2YVGH	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 24	DMF5TB4	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 25	DMRM3E9	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 26	DMYXLCJ	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 27	DMTDPHY	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 28	DMSNMZ2	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 29	DMCLTY3	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 3	DMAITK3	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 30	DMPLAWQ	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 31	DMMPJ3E	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 4	DMVF63N	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 5	DMRS1WG	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 6	DMEWA7U	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 7	DMD7053	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 8	DMWF2VG	Patented	Carbohydrates	[69]
Biaryl mannoside derivative 9	DM1Q7AL	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 1	DMS5UFX	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 10	DMITLPW	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 11	DMZF5XI	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 12	DMU0YST	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 13	DM83LTH	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 14	DMMRTWG	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 15	DM97BIQ	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 16	DMECZVG	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 17	DM7L8T5	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 18	DM2GZ5Y	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 19	DMGA0R6	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 2	DMQB4DR	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 20	DMDIYJ1	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 21	DMTR6BX	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 22	DMQGFKY	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 23	DMC8OVU	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 24	DMLUZ3K	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 25	DMBWQ8L	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 26	DM5Q4T2	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 27	DMWQ6FJ	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 28	DMMOTWK	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 29	DM9H0Q3	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 3	DMOKJEP	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 30	DM81RIY	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 4	DM0VR23	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 5	DMOS03R	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 6	DM93VEB	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 7	DM46NRV	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 8	DMZCWM5	Patented	Carbohydrates	[69]
Biphenyl mannoside derivative 9	DMP52HJ	Patented	Carbohydrates	[69]
C-linked disaccharide biphenyl mannoside derivative 1	DMV6H95	Patented	Carbohydrates	[69]
C-linked disaccharide biphenyl mannoside derivative 2	DMJT1WG	Patented	Carbohydrates	[69]
C-linked disaccharide biphenyl mannoside derivative 3	DMY10T2	Patented	Carbohydrates	[69]
C-linked disaccharide biphenyl mannoside derivative 4	DMRLE65	Patented	Carbohydrates	[69]
C-linked disaccharide biphenyl mannoside derivative 5	DMUG7E9	Patented	Carbohydrates	[69]
C-linked disaccharide biphenyl mannoside derivative 6	DMUILMD	Patented	Carbohydrates	[69]
Mannoside derivative 1	DMIE7U3	Patented	Carbohydrates	[69]
Mannoside derivative 10	DMZYRHN	Patented	Carbohydrates	[69]
Mannoside derivative 11	DM8I051	Patented	Carbohydrates	[69]
Mannoside derivative 12	DM4QUY0	Patented	Carbohydrates	[69]
Mannoside derivative 13	DM0U7P9	Patented	Carbohydrates	[69]
Mannoside derivative 2	DMFEQD2	Patented	Carbohydrates	[69]
Mannoside derivative 3	DMPF2UG	Patented	Carbohydrates	[69]
Mannoside derivative 4	DMZBY73	Patented	Carbohydrates	[69]
Mannoside derivative 5	DMMXNY8	Patented	Carbohydrates	[69]
Mannoside derivative 6	DMCM3NW	Patented	Carbohydrates	[69]
Mannoside derivative 7	DMOUT1F	Patented	Carbohydrates	[69]
Mannoside derivative 8	DMKTJAH	Patented	Carbohydrates	[69]
Mannoside derivative 9	DMIKZXD	Patented	Carbohydrates	[69]
PMID26651364-Compound-105	DMOJVK6	Patented	Carbohydrates	[69]
PMID26651364-Compound-106	DMQZJDF	Patented	Carbohydrates	[69]
PMID26651364-Compound-107	DMMZ1WL	Patented	Carbohydrates	[69]
PMID26651364-Compound-108	DMA7D3K	Patented	Carbohydrates	[69]
PMID26651364-Compound-109	DM01IWV	Patented	Carbohydrates	[69]
PMID26651364-Compound-10a	DMTPBNY	Patented	Carbohydrates	[69]
PMID26651364-Compound-10b	DM16ANH	Patented	Carbohydrates	[69]
PMID26651364-Compound-10c	DMCRNWA	Patented	Carbohydrates	[69]
PMID26651364-Compound-10d	DMGIV3C	Patented	Carbohydrates	[69]
PMID26651364-Compound-110	DMPA3IX	Patented	Carbohydrates	[69]
PMID26651364-Compound-111	DMY9R58	Patented	Carbohydrates	[69]
PMID26651364-Compound-112	DM1LIRP	Patented	Carbohydrates	[69]
PMID26651364-Compound-113	DM6OQKM	Patented	Carbohydrates	[69]
PMID26651364-Compound-114	DM5GHJA	Patented	Carbohydrates	[69]
PMID26651364-Compound-115	DMHIA26	Patented	Carbohydrates	[69]
PMID26651364-Compound-116	DMJ3201	Patented	Carbohydrates	[69]
PMID26651364-Compound-117a	DM6LXHS	Patented	Carbohydrates	[69]
PMID26651364-Compound-117b	DMUQSM1	Patented	Carbohydrates	[69]
PMID26651364-Compound-118	DM6ZRV4	Patented	Carbohydrates	[69]
PMID26651364-Compound-119	DMONAZI	Patented	Carbohydrates	[69]
PMID26651364-Compound-11b	DMGBFK3	Patented	Carbohydrates	[69]
PMID26651364-Compound-11c	DM76WBP	Patented	Carbohydrates	[69]
PMID26651364-Compound-120	DMZTBEQ	Patented	Carbohydrates	[69]
PMID26651364-Compound-121	DM4ZG0Q	Patented	Carbohydrates	[69]
PMID26651364-Compound-122	DMVFTIL	Patented	Carbohydrates	[69]
PMID26651364-Compound-123	DMR0E5W	Patented	Carbohydrates	[69]
PMID26651364-Compound-124	DM6VER5	Patented	Carbohydrates	[69]
PMID26651364-Compound-125	DMINUDB	Patented	Carbohydrates	[69]
PMID26651364-Compound-126a	DMSTKH6	Patented	Carbohydrates	[69]
PMID26651364-Compound-126b	DM2I1QZ	Patented	Carbohydrates	[69]
PMID26651364-Compound-126c	DM80PI1	Patented	Carbohydrates	[69]
PMID26651364-Compound-127	DMEN8RA	Patented	Carbohydrates	[69]
PMID26651364-Compound-128	DM4W0BX	Patented	Carbohydrates	[69]
PMID26651364-Compound-4	DMY0HP1	Patented	Carbohydrates	[69]
PMID26651364-Compound-45	DMLBZGO	Patented	Carbohydrates	[69]
PMID26651364-Compound-46	DMQFDU8	Patented	Carbohydrates	[69]
PMID26651364-Compound-47	DM4S5PB	Patented	Carbohydrates	[69]
PMID26651364-Compound-48	DMHXFGU	Patented	Carbohydrates	[69]
PMID26651364-Compound-49	DMMV5A9	Patented	Carbohydrates	[69]
PMID26651364-Compound-5	DMH7XL3	Patented	Carbohydrates	[69]
PMID26651364-Compound-50	DM6GFYR	Patented	Carbohydrates	[69]
PMID26651364-Compound-5a	DM01GVE	Patented	Carbohydrates	[69]
PMID26651364-Compound-5b	DMLHJ1E	Patented	Carbohydrates	[69]
PMID26651364-Compound-5c	DMDQTA2	Patented	Carbohydrates	[69]
PMID26651364-Compound-5d	DMF6Z5I	Patented	Carbohydrates	[69]
PMID26651364-Compound-5e	DM9TJR5	Patented	Carbohydrates	[69]
PMID26651364-Compound-5f	DMAZIY6	Patented	Carbohydrates	[69]
PMID26651364-Compound-5g	DMSW0HB	Patented	Carbohydrates	[69]
PMID26651364-Compound-6a	DM8HAJ3	Patented	Carbohydrates	[69]
PMID26651364-Compound-6b	DMBINOJ	Patented	Carbohydrates	[69]
PMID26651364-Compound-6c	DMPF86L	Patented	Carbohydrates	[69]
PMID26651364-Compound-6d	DM9J57W	Patented	Carbohydrates	[69]
PMID26651364-Compound-6e	DM4LF0X	Patented	Carbohydrates	[69]
PMID26651364-Compound-7a	DMQMBY9	Patented	Carbohydrates	[69]
PMID26651364-Compound-7b	DM3LCIM	Patented	Carbohydrates	[69]
PMID26651364-Compound-7c	DMGCUJB	Patented	Carbohydrates	[69]
PMID26651364-Compound-7d	DM89VQT	Patented	Carbohydrates	[69]
PMID26651364-Compound-7e	DM2SZ0B	Patented	Carbohydrates	[69]
PMID26651364-Compound-8a	DM1M3WF	Patented	Carbohydrates	[69]
PMID26651364-Compound-8b	DMYVU36	Patented	Carbohydrates	[69]
PMID26651364-Compound-8c	DME7UNT	Patented	Carbohydrates	[69]
PMID26651364-Compound-8d	DMSO2F8	Patented	Carbohydrates	[69]
PMID26651364-Compound-9a	DMAXWPS	Patented	Carbohydrates	[69]
PMID26651364-Compound-9b	DM6HTU0	Patented	Carbohydrates	[69]
PMID26651364-Compound-9c	DM49V8G	Patented	Carbohydrates	[69]
PMID26651364-Compound-9d	DMF0L3E	Patented	Carbohydrates	[69]
PMID26651364-Compound-9e	DM9FIKD	Patented	Carbohydrates	[69]
PMID26651364-Compound-9f	DMF1MV6	Patented	Carbohydrates	[69]
------------------------------------------------------------------------------------


⏷ Show the Full List of 188 Drug(s)

This Disease is Treated as An Indication in 2 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Pidotimod	DMK9BRV	Withdrawn from market	Small molecular drug	[20]
Sulfametopyrazine	DMBCK2S	Withdrawn from market	Small molecular drug	[70]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 1 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
mAb926	DMNO20J	Preclinical	Antibody	[71]
------------------------------------------------------------------------------------

This Disease is Treated as An Indication in 2 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Thiolactomycin	DMBAWDG	Investigative	Small molecular drug	[1]
ZP-012	DMKECWK	Investigative	NA	[1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

This Disease Is Related to 18 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
CAMP	TTULOB6	Limited	Biomarker	[73]
CD248	TTYJWT7	Limited	Biomarker	[74]
KLK3	TTS78AZ	Limited	Biomarker	[75]
LCN2	TTKTLAI	Limited	Biomarker	[76]
NR3C2	TT26PHO	Limited	Genetic Variation	[77]
DEFB4A	TTIVY12	moderate	Altered Expression	[78]
TLR5	TTCXP8J	moderate	Altered Expression	[79]
TREM1	TTHZQP0	moderate	Altered Expression	[80]
DAPK3	TTERVQN	Strong	Biomarker	[81]
GPR182	TTT23CG	Strong	Biomarker	[82]
HEXA	TTJI5JW	Strong	Biomarker	[83]
IL18	TTRICUF	Strong	Biomarker	[84]
IL1A	TTPM6HI	Strong	Biomarker	[84]
LY96	TT8S9AV	Strong	Biomarker	[85]
MBL2	TTMQDZ5	Strong	Altered Expression	[86]
NOS2	TTF10I9	Strong	Biomarker	[87]
PCYT1B	TTUAIKM	Strong	Biomarker	[88]
POMC	TT21AKM	Strong	Biomarker	[89]
------------------------------------------------------------------------------------


⏷ Show the Full List of 18 DTT(s)

This Disease Is Related to 2 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC14A2	DT8QC7K	Strong	Genetic Variation	[90]
SLC9A6	DTN0JXW	Strong	Biomarker	[91]
------------------------------------------------------------------------------------

This Disease Is Related to 2 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
NT5C2	DE1DOKJ	moderate	Biomarker	[92]
LARS2	DEP7BTH	Strong	Biomarker	[93]
------------------------------------------------------------------------------------

This Disease Is Related to 40 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
IREB2	OT747D24	Limited	Biomarker	[94]
AMBP	OTLU8GU8	moderate	Biomarker	[95]
CABIN1	OT4G5CIK	moderate	Biomarker	[79]
CORO7	OTG7MEAJ	moderate	Biomarker	[96]
NHS	OTKE8QAT	moderate	Genetic Variation	[97]
NPHS1	OT21JD3P	moderate	Biomarker	[98]
RNASE7	OTIXO0Z4	moderate	Biomarker	[99]
TCF21	OT393IMA	moderate	Biomarker	[96]
AZU1	OTHXU264	Strong	Biomarker	[100]
CCL18	OT7JYSK9	Strong	Genetic Variation	[101]
CTBS	OT135K92	Strong	Biomarker	[88]
CUL9	OTPUCLZT	Strong	Genetic Variation	[101]
CYLD	OT37FKH0	Strong	Biomarker	[102]
DERL2	OTI3TUUZ	Strong	Genetic Variation	[103]
DNAAF3	OT3OHO0O	Strong	Biomarker	[104]
DNAH5	OTC21RUS	Strong	Biomarker	[104]
DNAI1	OTF6C65Q	Strong	Biomarker	[104]
GNLY	OTZJKA8C	Strong	Biomarker	[105]
HM13	OTGEO1LP	Strong	Biomarker	[106]
HMX1	OT65ZGE0	Strong	Biomarker	[107]
IMMP1L	OTA6LOLR	Strong	Biomarker	[106]
LARS1	OT4557NF	Strong	Biomarker	[93]
LYPD4	OTYNO8BS	Strong	Biomarker	[108]
MARCHF10	OTAYGHDM	Strong	Biomarker	[109]
MUC7	OTSTMP0X	Strong	Altered Expression	[110]
NLRC4	OTAIA3NA	Strong	Biomarker	[111]
OXA1L	OTS0BFRD	Strong	Biomarker	[112]
PACC1	OTKBS8CC	Strong	Biomarker	[113]
PCBD1	OTDSRUD5	Strong	Biomarker	[104]
PFKM	OT1QY9JM	Strong	Genetic Variation	[114]
PLEKHB1	OTC7TNAX	Strong	Genetic Variation	[115]
RNASE1	OTKZ7CO9	Strong	Genetic Variation	[116]
RRH	OTKHIYYT	Strong	Biomarker	[117]
SCNN1G	OTSJYQVQ	Strong	Biomarker	[118]
SERPINF2	OTZGAF8B	Strong	Genetic Variation	[119]
SFTPA2	OT6SFOMU	Strong	Biomarker	[120]
SFXN1	OTL66767	Strong	Biomarker	[110]
SPESP1	OTWXKKTJ	Strong	Biomarker	[121]
SPI1	OTVCA1D0	Strong	Biomarker	[122]
TNMD	OTHLVA9G	Strong	Biomarker	[102]
------------------------------------------------------------------------------------


⏷ Show the Full List of 40 DOT(s)

References

1	The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
2	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018749.
3	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6289).
4	Amoxicillin FDA Label
5	Amphotericin B FDA Label
6	Ampicillin FDA Label
7	Azlocillin FDA Label
8	Aztreonam FDA Label
9	Bacampicillin FDA Label
10	Carbenicillin FDA Label
11	Cefaclor FDA Label
12	Cefadroxil FDA Label
13	Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54.
14	Cefamandole FDA Label
15	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
16	Cefixime FDA Label
17	Cefmetazole FDA Label
18	Cefonicid FDA Label
19	[Bacterial pathogens and resistance patterns in community acquired pediatric urinary tract infection: experience of 152 cases]. Zhongguo Dang Dai Er Ke Za Zhi. 2006 Apr;8(2):115-7.
20	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
21	Ceftizoxime FDA Label
22	Cephapirin FDA Label
23	Clavulanate FDA Label
24	Cyclacillin FDA Label
25	Demeclocycline FDA Label
26	2007 FDA drug approvals: a year of flux. Nat Rev Drug Discov. 2008 Feb;7(2):107-9.
27	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 019616.
28	Erythromycin FDA Label
29	2014 FDA drug approvals. Nat Rev Drug Discov. 2015 Feb;14(2):77-81.
30	Fosfomycin FDA Label
31	Prostatectomy and infection. J Urol. 1971 Dec;106(6):910-2.
32	Isolation of Staphylococcus aureus Urinary Tract Infections at a Community-Based Healthcare Center in Riyadh. Cureus. 2023 Feb 18;15(2):e35140.
33	Kanamycin FDA Label
34	Lomefloxacin FDA Label
35	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050549.
36	Minocycline FDA Label
37	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 071919.
38	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 009175.
39	Norfloxacin FDA Label
40	Ofloxacin FDA Label
41	Oxytetracycline FDA Label
42	Piperacillin FDA Label
43	Drug information of Pivmecillinam, 2008. eduDrugs.
44	In vitro activity of plazomicin against -lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).J Antimicrob Chemother. 2017 Oct 1;72(10):2792-2795.
45	Polymyxin B Sulfate FDA Label
46	Prulifloxacin: a new antibacterial fluoroquinolone. Expert Rev Anti Infect Ther. 2006 Feb;4(1):27-41.
47	FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 017569.
48	How many modes of action should an antibiotic have Curr Opin Pharmacol. 2008 Oct;8(5):564-73.
49	Tetracycline FDA Label
50	Ticarcillin FDA Label
51	Has nature already identified all useful antibacterial targets Curr Opin Microbiol. 2008 Oct;11(5):387-92.
52	Trovafloxacin FDA Label
53	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4781).
54	ClinicalTrials.gov (NCT03687255) Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections. U.S. National Institutes of Health.
55	ClinicalTrials.gov (NCT04020341) A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI). U.S. National Institutes of Health.
56	ClinicalTrials.gov (NCT03357614) Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults. U.S. National Institutes of Health.
57	ClinicalTrials.gov (NCT03788967) Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (ADAPT-PO). U.S. National Institutes of Health.
58	ClinicalTrials.gov (NCT02166476) Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP. U.S. National Institutes of Health.
59	ClinicalTrials.gov (NCT04505683) A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP). U.S. National Institutes of Health.
60	ClinicalTrials.gov (NCT03151967) Lactobacillus Probiotic for Prevention of UTI. U.S. National Institutes of Health.
61	ClinicalTrials.gov (NCT01381549) GSK2251052 in Complicated Urinary Tract Infection. U.S. National Institutes of Health.
62	ClinicalTrials.gov (NCT03377426) LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI). U.S. National Institutes of Health.
63	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033290)
64	ClinicalTrials.gov (NCT03491748) A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ETX0282 Administered in Healthy Subjects. U.S.National Institutes of Health.
65	ClinicalTrials.gov (NCT05138822) A Double-Blind, Double Dummy, Randomized, Phase 1b, Nitrofurantoin Controlled, Repeat Oral Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Microbiological Response of GSK3882347 in Female Participants With Acute Uncomplicated Urinary Tract Infection. U.S.National Institutes of Health.
66	ClinicalTrials.gov (NCT04191148) Safety, Tolerability, and PK of LBP-EC01 in Patients With Lower Urinary Tract Colonization Caused by E. Coli. U.S. National Institutes of Health.
67	Clinical pipeline report, company report or official report of Roche
68	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
69	Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease.Expert Opin Ther Pat. 2016;26(2):175-97.
70	Drug information of Sulfametopyrazine, 2008. eduDrugs.
71	Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017 Jul;16(7):457-471.
72	2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
73	Use of ceragenins as a potential treatment for urinary tract infections.BMC Infect Dis. 2019 May 2;19(1):369. doi: 10.1186/s12879-019-3994-3.
74	The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection.Ann Clin Microbiol Antimicrob. 2018 Feb 13;17(1):4. doi: 10.1186/s12941-018-0256-y.
75	Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.J Endourol. 2020 Feb;34(2):184-191. doi: 10.1089/end.2019.0430. Epub 2019 Nov 8.
76	Predictive ability of NGAL in identifying urinary tract infection in children with neurogenic bladders.Pediatr Nephrol. 2018 Aug;33(8):1365-1374. doi: 10.1007/s00467-018-3936-0. Epub 2018 Mar 12.
77	Clinical features, genetic background, and outcome in infants with urinary tract infection and type IV renal tubular acidosis.Pediatr Res. 2020 Jun;87(7):1251-1255. doi: 10.1038/s41390-019-0727-7. Epub 2019 Dec 18.
78	Association between vitamin D, antimicrobial peptides and urinary tract infection in infants and young children.Acta Paediatr. 2019 Mar;108(3):551-556. doi: 10.1111/apa.14499. Epub 2018 Aug 7.
79	Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection.Sci Rep. 2019 Jan 14;9(1):106. doi: 10.1038/s41598-018-37482-x.
80	Urine TREM-1 as a marker of urinary tract infection in children.J Int Med Res. 2017 Apr;45(2):631-638. doi: 10.1177/0300060517696199. Epub 2017 Apr 2.
81	Algorithms Using Previous Resistance, Prior Antimicrobial Prescriptions, and Patient Place of Residence Enhance Empirical Therapy for Women With Uncomplicated Urinary Tract Infections.Urology. 2020 Mar;137:72-78. doi: 10.1016/j.urology.2019.11.009. Epub 2019 Nov 17.
82	Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteriuria.J Glob Antimicrob Resist. 2020 Mar;20:60-67. doi: 10.1016/j.jgar.2019.11.009. Epub 2019 Nov 18.
83	Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).Microb Pathog. 2018 Aug;121:123-130. doi: 10.1016/j.micpath.2018.05.024. Epub 2018 May 17.
84	Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation.BMC Infect Dis. 2009 Jan 26;9:9. doi: 10.1186/1471-2334-9-9.
85	LY96, UPKIB mutations and TLR4, CD14, MBL polymorphisms in children with urinary tract infection.Indian J Pediatr. 2011 Oct;78(10):1229-33. doi: 10.1007/s12098-011-0399-8. Epub 2011 Mar 9.
86	The association of mannose-binding lectin 2 polymorphisms with outcome in very low birth weight infants.PLoS One. 2017 May 30;12(5):e0178032. doi: 10.1371/journal.pone.0178032. eCollection 2017.
87	Bacterial infection induces nitric oxide synthase in human neutrophils.J Clin Invest. 1997 Jan 1;99(1):110-6. doi: 10.1172/JCI119121.
88	In Vivo Pharmacodynamic Profile of Ceftibuten-Clavulanate Combination against Extended-Spectrum--Lactamase-Producing Enterobacteriaceae in the Murine Thigh Infection Model.Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00145-19. doi: 10.1128/AAC.00145-19. Print 2019 Jul.
89	Adrenocorticotropic hormone versus methylprednisolone added to interferon in patients with multiple sclerosis experiencing breakthrough disease: a randomized, rater-blinded trial.Ther Adv Neurol Disord. 2017 Jan;10(1):3-17. doi: 10.1177/1756285616670060. Epub 2016 Oct 19.
90	Association between ICAM-1 Gly-Arg polymorphism and renal parenchymal scarring following childhood urinary tract infection.Int J Immunogenet. 2006 Feb;33(1):49-53. doi: 10.1111/j.1744-313X.2006.00565.x.
91	Erythematous plaques and papules on a premature infant.J Am Acad Dermatol. 2017 Apr;76(4):e111-e112. doi: 10.1016/j.jaad.2016.08.038.
92	Cyclic Di-GMP Signaling Contributes to Pseudomonas aeruginosa-Mediated Catheter-Associated Urinary Tract Infection.J Bacteriol. 2015 Jul 20;198(1):91-7. doi: 10.1128/JB.00410-15. Print 2016 Jan 1.
93	Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. Antimicrob Agents Chemother. 2015 Jan;59(1):289-98.
94	Contribution of yersiniabactin to the virulence of an Escherichia coli sequence type 69 ("clonal group A") cystitis isolate in murine models of urinary tract infection and sepsis.Microb Pathog. 2018 Jul;120:128-131. doi: 10.1016/j.micpath.2018.04.048. Epub 2018 Apr 24.
95	Combination of Coral UTI Screen(TM) system, gram-stain and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for diagnosis of urinary tract infections directly from urine samples.J Chemother. 2019 Apr;31(2):74-80. doi: 10.1080/1120009X.2019.1573284. Epub 2019 Feb 20.
96	Outcomes of Early Removal of Urinary Catheter Following Rectal Resection for Cancer.Ann Surg Oncol. 2019 Jan;26(1):79-85. doi: 10.1245/s10434-018-6822-x. Epub 2018 Oct 23.
97	Long-term outcomes of urinary tract infection (UTI) in Childhood (LUCI): protocol for an electronic record-linked cohort study.BMJ Open. 2019 Apr 20;9(4):e024210. doi: 10.1136/bmjopen-2018-024210.
98	Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.BMC Microbiol. 2017 May 25;17(1):127. doi: 10.1186/s12866-017-1036-0.
99	Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic Escherichia coli Infection.J Am Soc Nephrol. 2019 Aug;30(8):1385-1397. doi: 10.1681/ASN.2018090929. Epub 2019 Jun 25.
100	New markers of urinary tract infection.Clin Chim Acta. 2017 Aug;471:286-291. doi: 10.1016/j.cca.2017.06.003. Epub 2017 Jun 13.
101	High frequency of aac(6')-Ib-cr gene associated with double mutations in gyrA and parC in Escherichia coli isolates from patients with urinary tract infections.J Glob Antimicrob Resist. 2018 Jun;13:180-183. doi: 10.1016/j.jgar.2017.12.013. Epub 2018 Jan 4.
102	Carbapenem-Resistant KPC- and TEM-Producing Escherichia coli ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018.Microb Drug Resist. 2020 Jan;26(1):38-45. doi: 10.1089/mdr.2019.0085. Epub 2019 Aug 6.
103	Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients.J BUON. 2019 Sep-Oct;24(5):1768-1775.
104	Is there a conflict between general practitioners applying guidelines for antibiotic prescribing and including their patients' preferences?.Patient Prefer Adherence. 2017 Dec 21;12:9-19. doi: 10.2147/PPA.S147616. eCollection 2018.
105	The selective biomarker IL-8 identifies IFTA after kidney transplantation in blood cells.Transpl Immunol. 2016 Nov;39:18-24. doi: 10.1016/j.trim.2016.09.003. Epub 2016 Sep 29.
106	Detection of VIM-1 and IMP-1 genes in Klebsiella pneumoniae and relationship with biofilm formation.Microb Pathog. 2018 Feb;115:25-30. doi: 10.1016/j.micpath.2017.12.036. Epub 2017 Dec 14.
107	MiR-204/miR-211 downregulation contributes to candidemia-induced kidney injuries via derepression of Hmx1 expression.Life Sci. 2014 May 2;102(2):139-44. doi: 10.1016/j.lfs.2014.03.010. Epub 2014 Mar 15.
108	YnfA , a SMR family efflux pump is abundant in Escherichia coli isolates from urinary infection.Indian J Med Microbiol. 2015 Jan-Mar;33(1):139-42. doi: 10.4103/0255-0857.148415.
109	Prevalence and predictive factors of urinary tract infection among patients with stroke: A meta-analysis.Am J Infect Control. 2018 Apr;46(4):402-409. doi: 10.1016/j.ajic.2017.10.001. Epub 2017 Nov 16.
110	Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients.Int J Urol. 2004 Jan;11(1):38-43. doi: 10.1111/j.1442-2042.2004.00739.x.
111	Involvement of NLRP3 and NLRC4 Inflammasome in Uropathogenic E. coli Mediated Urinary Tract Infections.Front Microbiol. 2019 Sep 3;10:2020. doi: 10.3389/fmicb.2019.02020. eCollection 2019.
112	Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31.
113	Antiadhesive Activity and Metabolomics Analysis of Rat Urine after Cranberry (Vaccinium macrocarpon Aiton) Administration.J Agric Food Chem. 2017 Jul 19;65(28):5657-5667. doi: 10.1021/acs.jafc.7b01856. Epub 2017 Jul 5.
114	Flexible Metabolism and Suppression of Latent Enzymes Are Important for Escherichia coli Adaptation to Diverse Environments within the Host.J Bacteriol. 2019 Jul 24;201(16):e00181-19. doi: 10.1128/JB.00181-19. Print 2019 Aug 15.
115	Contribution of fucose-containing capsules in Klebsiella pneumoniae to bacterial virulence in mice.Exp Biol Med (Maywood). 2008 Jan;233(1):64-70. doi: 10.3181/0706-RM-170.
116	The Responses of the Ribonuclease A Superfamily to Urinary Tract Infection.Front Immunol. 2019 Nov 29;10:2786. doi: 10.3389/fimmu.2019.02786. eCollection 2019.
117	Comparative analysis of genitourinary function after type C1 robotic nerve-sparing radical hysterectomy versus type C2 robotic radical hysterectomy.Surg Oncol. 2019 Sep;30:58-62. doi: 10.1016/j.suronc.2019.05.003. Epub 2019 May 11.
118	Transient pseudohypoaldosteronism in infancy secondary to urinary tract infection.J Paediatr Child Health. 2017 May;53(5):458-463. doi: 10.1111/jpc.13481. Epub 2017 Feb 24.
119	Aerococcus urinae and Aerococcus sanguinicola, two frequently misidentified uropathogens.Scand J Infect Dis. 2010 Oct;42(10):775-80. doi: 10.3109/00365548.2010.485576.
120	Innate immunity of surfactant proteins A and D in urinary tract infection with uropathogenic Escherichia coli.Innate Immun. 2016 Jan;22(1):9-20. doi: 10.1177/1753425915609973. Epub 2015 Oct 28.
121	Survey for virulence determinants among Enterococcus faecalis isolated from different sources.J Med Microbiol. 2004 Jan;53(Pt 1):13-20. doi: 10.1099/jmm.0.05353-0.
122	The Escherichia coli Type III Secretion System 2 Has a Global Effect on Cell Surface.mBio. 2018 Jul 3;9(4):e01070-18. doi: 10.1128/mBio.01070-18.